Physician
Pathology
Dr. Kedar V. Inamdar, MD
|
|
Give Review
Kedar Inamdar is an expert in the field of Pathology. He attended Bharti Vidyapeeth Medical College. Kedar Inamdar is a published MD. He has 18 publications published. The most current publication "A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders." He is registered with Medicare.
Publications
- A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative Disorders.
- Differential expression of aurora-A kinase in T-cell Lymphomas.
- Blastic plasmacytoid dendritic Cell neoplasm.
- Cystic tumor of the atrioventricular node: an unexpected finding in an explanted heart.
- Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell Lymphoma treated with hyper-CVAD and rituximab, alternating with r...
- Proliferation predicts failure-free survival in mantle cell Lymphoma patients treated with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin,...
- Aurora-A kinase nuclear expression in chronic lymphocytic leukemia.
- nm23-H1 expression in non-Hodgkin and Hodgkin Lymphomas.
- Bone marrow involvement by marginal zone B-cell Lymphomas of different types.
- Pathology of chronic lymphocytic leukemia: an update.
- DNA end sequestration by DNA-dependent protein kinase and end joining of sterically constrained substrates in whole-Cell extracts.
- Base substitutions, targeted single-base deletions, and chromosomal translocations induced by bleomycin in plateau-phase mammary epithelial Cells.
- Conversion of phosphoglycolate to phosphate termini on 3' overhangs of DNA double strand breaks by the human tyrosyl-DNA phosphodiesterase hTdp1.
- Resistance of 3'-phosphoglycolate DNA ends to digestion by mammalian DNase III.
- The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell Lymphoma from Hodgkin Lymphoma.
- Accurate in vitro end joining of a DNA double strand break with partially cohesive 3'-overhangs and 3'-phosphoglycolate termini: effect of Ku on repair fidelity.
- High serum thymidine kinase 1 level predicts poorer survival in patients with chronic lymphocytic leukemia.
Schools
Bharati Vidyapeeth Deemed University Medical College Hospital
Henry Ford Hospital
University of Texas MD Anderson Cancer Center
Conditions Treated
- Anemia
- Hodgkin's Disease
- Leukocytosis
- Myeloproliferative Disorders
- View All
Doctors Specialties
- Hematology
- Hematopathology
- Pathology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna
- Cofinity PPO
- Health Alliance
- Medicare MCR
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
University of Texas MD Anderson Cancer Center -
Henry Ford Hospital - Wayne State University -
Bharti Vidyapeeth Medical College
Hospital
-
Henry Ford Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1093890469 |
| Last Name Of The Provider | INAMDAR |
| First Name Of The Provider | KEDAR |
| View All |
Similar Doctors
|
|
Dr. Jessica L. Schering, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christian E. Keller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sajal P. Choudhury, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Doina David, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Koichi Maeda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kinda Hayek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Linda J. Szymanski, DO |
|
|
Dr. Hongfeng Yu, MD |